Role of KATP Channel Loss in Type 2 Diabetes (NCT06830096)
Hyperglycemia Induced Hyperexcitability: A Novel Role for KATP in the Progression of Type 2 Diabetes
๐ฉบ Plain-English Summary (8th-Grade Level)
Insulin is a hormone that is made by ฮฒ-cells in the pancreas and when released into the bloodstream helps control blood sugar levels. Insulin release is regulated by electrical activity in the ฮฒ-cell which is generated by the ATP-sensitive potassium (KATP) channel. While reduced KATP activity is associated with increased insulin secretion, animals lacking KATP exhibit reduced secretion. This crossover from hypersecretion to undersecretion with KATP loss mirrors insulin secretion during type 2 diabetes. Intriguingly, evidence from cell and animal models suggest that chronically stimulated ฮฒ-cells can lose KATP revealing a possible role for KATP loss in the failure of insulin secretion and poor control of blood sugar observed in type 2 diabetes. This study will therefore examine insulin responses following ingestion of a single dose of a sulfonylurea called glipizide that inhibits KATP channels in people with and without type 2 diabetes. The goal is to determine whether KATP channel activity is reduced during type 2 diabetes progression.
Who can join: Review the eligibility criteria below.
Location: Washington University in St. Louis โ St Louis, Missouri
Age range: 18 Years to 65 Years
๐งช Interventions in This Study
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (1 Sites)
- Washington University in St. Louis โ St Louis, Missouri
๐ Contact the Study Coordinator
Phone: (314) 273-1879
Email: nutritionresearch@wustl.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Obesity and Type 2 Diabetes
- Investigating Metabolic and Psychological Adaptations in a Clinical Trial โ Buffalo, New York
- Mobile Regulation of Craving Training (mROC-T) to Improve Dietary Intake in Rural Adolescent Girls โ Laramie, Wyoming
- Adapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents โ Houston, Texas
- Effects of HIIT vs. TRE on Type 2 Diabetes Risk โ Syracuse, New York
- Regional Adipose Tissue Characteristics in Type II Diabetes โ Montreal, Quebec
Explore by condition: All Obesity and Type 2 Diabetes clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.